The Breaking "Bad Rest" Study: Interrupting Sedentary Time to Reverse

Status Completed

Clinical Trial Summary

This study will determine whether an intervention aimed at reducing sedentary time in patients admitted to acute care will result in decreased frailty levels at hospital discharge, compared to the current standard of care. All patients will be fitted with accelerometers then randomised to the control or intervention group. The control group will receive only standard of care while in hospital. Participants in the intervention group will engage in daily goal setting for time out-of-bed and have access to real-time feedback on a bedside monitor. Participants in the intervention group will also received assisted mobilization if they have not met their daily goal by the late afternoon. The main outcome is frailty, assessed by a frailty index.

Clinical Trial Description

The objective of this study is to determine if an intervention designed to reduce sedentary time during a patient's stay in acute care will reduce patient's frailty levels more so than current standard of care. This study will be conducted at a single-centre, but will be a stratified, block randomised control trial. Fifty participants will be recruited within 24 hours of admission to a geriatric acute care unit. Both groups will be fitted with a device that measures sedentary and active time (accelerometer). Participants in the intervention group will have a daily goal for activity and will be provided with real-time feedback on attainment of that goal displayed on a bedside tablet. Participants in the intervention group who do not independently achieve their goal will be assisted in reducing their sedentary time in the afternoon and/or early evening to the maximum level of their ability; this level will be determined in consultation with the healthcare team. The primary outcome is a change in frailty during hospitalization, measured using a 30-item frailty index. The data collection phase is approximately 10 months. Data analysis will take an additional six months (16 months total). Knowledge-users will be involved during all stages of the project. The data generated from this study will enable us to scale up this intervention nationally and internationally. If the intervention is successful, it will warrant a study to implement the intervention as part of standard care. Ultimately, this study will inform guidelines to limit patients' sedentary behaviors in acute care. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03682523
Study type	Interventional
Source	Nova Scotia Health Authority
Contact
Status	Completed
Phase	N/A
Start date	April 7, 2022
Completion date	July 20, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02385591` - Innovative Physical Activity Interventions for Overweight Latinos	N/A
Completed	`NCT02672215` - RCT Computer-tailored Intervention on Workplace Sitting	N/A
Completed	`NCT03305731` - Activating Behavior for Lasting Engagement After Stroke	N/A
Completed	`NCT02994134` - Exercise, Cognitive Function and Neuroplasticity in Healthy Adults	N/A
Recruiting	`NCT04195165` - The Effect of Sitting and Moderate Exercise on Plasma Insulin and Glucose Responses to an Oral Glucose Tolerance Test	N/A
Completed	`NCT03119610` - The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity	Phase 1/Phase 2
Active, not recruiting	`NCT02467881` - Physical Activity and Sedentary Behavior Change; Impact on Lifestyle	N/A
Completed	`NCT02342301` - Cardiometabolic Response to Sit-stand Workstations.	N/A
Terminated	`NCT02254902` - Physical Activity and Education Program for Somali Women	N/A
Completed	`NCT01975870` - A stAPP to a Healthier Lifestyle	N/A
Completed	`NCT02024061` - Treatment of Pediatric Obesity (TOP) - A Multidisciplinary Approach Involving Adolescents and Their Peers	N/A
Completed	`NCT02960750` - Effectiveness of a Workplace "Sit Less and Move More" Web-based Program in Spanish Office Employees (Walk@WorkSpain)	N/A
Completed	`NCT00183014` - Caminemos! Trial to Increase Walking Among Sedentary Older Latinos	N/A
Completed	`NCT04049162` - Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency	N/A
Completed	`NCT03283904` - Active Schools: Skelmersdale	N/A
Completed	`NCT03694951` - The Effect of Experimentally Decreasing Sedentary Behaviour on Subjective Well-being	N/A
Enrolling by invitation	`NCT04019119` - Digital Intervention for the Modification of Lifestyles (iGame)	N/A
Completed	`NCT03109535` - MapTrek for Sedentary Workers	N/A
Completed	`NCT03993652` - Kids FIRST: Family-based Intervention to Reduce Snacking and Screen Time in Children	N/A
Completed	`NCT00891514` - Trial of Aerobic Exercise Training in Stroke Survivors	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Breaking "Bad Rest" Study: Interrupting Sedentary Time to Reverse Frailty Levels in Acute Care

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms